Pediatric Safety Guidelines for Hyoscine Use

Respiratory and Airway Risks in Young Children

The American Academy of Pediatrics warns that children under six years are especially prone to respiratory depression, airway obstruction, and loss of protective reflexes during sedation or medication administration, underscoring the need for heightened vigilance in this age group. 1

When scopolamine is employed for its antisialagogue (dry‑mouth reducing) effect, the American Academy of Pediatrics recommends using the lowest effective dose and maintaining continuous physiologic monitoring to promptly detect any anticholinergic toxicity. 1

The American Academy of Pediatrics emphasizes that clinicians must have rescue protocols in place and be prepared to manage a level of sedation one tier deeper than originally intended, ensuring rapid response to unexpected adverse events. 1

The American Academy of Pediatrics recommends pentobarbital 2-6 mg/kg IV, titrated to effect, for procedural sedation 2, 3
Midazolam 0.2-0.3 mg/kg IV is often used, often combined with fentanyl for painful procedures 4

The American Academy of Pediatrics states that children younger than 6 years, particularly those younger than 6 months, are at greatest risk of adverse events during sedation 5, 6
Practitioners must have skills to rescue patients from one level deeper than intended, and continuous physiologic monitoring and presence of personnel not performing the procedure are essential 5, 6
The American Academy of Pediatrics recommends structured sedation protocols with continuous observation to allow rapid diagnosis of complications 5, 6